Not fake, not proven, but plausible and monitorable
Patients on GLP-1 medications who experience ongoing gastrointestinal issues should consult their healthcare provider to assess whether adjustments to their treatment plan are needed
It causes breathing difficulties, coughing, wheezing, and tightness in the chest
So yeah, the path forward is uncertain
While the risk of pancreatitis has been known since clinical trials, more evidence is emerging that medicines such as Ozempic can be associated with other gastrointestinal complications that can have serious consequences such as gastroparesis (stomach paralysis) and ileus (bowel obstruction through more generalised intestinal paralysis)
The FDA has given traditional pharmacies 60 days (until late April 2025) and outsourcing facilities 90 days (until late May 2025) to cease compounding, distributing, or dispensing semaglutide, with similar timelines applied to tirzepatide earlier